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INTRODUCTION
Today, cost analyses for coronary artery bypass and valve surgery have gained more importance. Duration of intensive care unit (ICU) and hospital stay of patients is among the main factors determining the cost of treatment. Although patients undergo similar surgical procedures and are monitored in the same unit, the duration of ICU and hospital stay may vary. Concomitant diseases of patients should be carefully evaluated and treated, then the treatment costs of patients who undergo coronary bypass and valve surgery can be reduced (1) . It is of primary importance to predefine risk factors that trigger such conditions such as prolonged intubation and ICU stay, which may affect the cost.
Several studies have revealed that as a systemic disease, chronic obstructive pulmonary disease (COPD) is an important risk factor in patients undergoing valve and coronary surgery (2, 3) . Specified risk scoring methods also indicate that COPD is a risk factor in surgical procedures (4) .
It is essential that preoperative risk factors are assessed with additional tests and supported with additional treatments. There may be differences in clinical studies since duration of postoperative intubation and ICU stay in coronary bypass and valve surgery depends on multiple interrelated factors. The aim of the present study is to reveal the relationship between postoperative morbidity and preoperative airway obstruction determined by preoperative assessment in patients undergoing mitral valve replacement, and to present the importance of preoperative assessment.
METHODS
Following the Ethics Committee approval of our University, we included 62 consecutive patients who underwent mitral valve replacement. We recorded the presence of airway obstruction diagnosed in the preoperative period. All patients' sex, presence of systemic disease and smoking history were recorded. Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio and mid-expiratory flow (MEF) 25-75% values were recorded in spirometric measurements (ZAN 100 Pulmonary Spirometer, Colorado, USA). Echocardiography values were performed using GE-VingMed Vivid S5 Echo Doppler Ultrasound. Ejection fraction (EF), systolic pulmonary artery pressure (sPAP), degree of mitral regurgitation (MR) and tricuspid regurgitation (TR) were recorded. Durations of preoperative cardiopulmonary bypass (CPB) and aortic crossclamp (XCL) were recorded. Duration of intubation and length of ICU stay were also recorded. Preoperative and postoperative aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), creatinine and blood gas values (pH, carbon dioxide (CO2), oxygen (O2), hematocrit and glucose) were recorded using the Cobas 6000 analyzer series.
Patients who underwent only mitral valve replacement were considered as single-operation patients, while patients who underwent coronary bypass, aortic valve replacement or tricuspid annuloplasty and/or valve replacement in addition to mitral valve replacement were considered as multiple-operation patients.
Statistical Analysis
Statistical Package for Social Sciences (SPSS) 22.0 (IBM Corp, Armonk, NY, USA) was applied for statistical analysis. Quantitative data was analyzed using the ANOVA, Kruskal-Wallis and Mann-Whitney U tests. The Wilcoxon test was used for repeated measures. Qualitative data analysis was performed with the Chi-square test or the Fischer Test when the Chi-square test conditions could not be met.
RESULTS
A total of 62 patients undergoing mitral valve replacement were included in the study. Twenty of them underwent combined surgery. The number of female patients were 36 (58.1%) and 26 (41.9%) were male. Forty-two patients underwent only mitral valve replacement while 20 had combined surgery. Forty-seven patients (75.8%) had a concomitant systemic disease. In the preoperative assessment, 9 patients (14.5%) were diagnosed with asthma and 8 patients (12.9%) were diagnosed with chronic obstructive pulmonary disease (COPD). Seventeen of all patients (27.7%) had a history of smoking. Ten (16.1%) of the patients were diagnosed with COPD and asthma with a history of medication ( The duration of intubation did not show any significant difference between male and female patients (p>0.05), as well as between the singleoperation and multiple-operation patients (p >0.05), between patients with respiratory tract disease and those without (p>0.05), between smoking and nonsmoking patients (p>0.05), between patients with asthma and those without (p>0.05), between patients with COPD and those without (p>0.05), between patients with a history of medication and those without (p>0.05), and lastly between patients with systemic disease and those without (p>0.05) ( Table 2) . The duration of ICU stay did not show any significant difference between male and female patients (p>0.05), as well as between the singleoperation and multiple-operation patients (p>0.05). The duration of ICU stay was significantly shorter in patients with respiratory tract disease than in patients without the disease (p<0.05). The duration of ICU stay did not show any significant difference between smoking and non-smoking patients as well as between patients with asthma and those without the disease (p>0.05). However, the duration of ICU stay was significantly shorter in patients with COPD than in patients without the disease (p<0.05). The duration of ICU stay was also significantly shorter in patients with a history of medication than in patients without a history of medication (p<0.05). The duration of ICU stay did not show any significant difference between patients with systemic disease and those without (p>0.05) ( Table  3) . There was a significant positive correlation between the duration of intubation and CPB time, preoperative-postoperative BUN, and postoperative creatinine level (p<0.05). There was a significant negative correlation between the duration of intubation and FEV1 value (p<0.05). No significant positive correlation was found between the duration of intubation and XCL, FEV1%, FVC%, FVC, FEV1/FVC, MEF%, MEF, EF, sPAP, mitral regurgitation, tricuspid regurgitation, CO2, O2, glucose, Ph, preoperative creatinine, preoperativepostoperative hematocrit, preoperativepostoperative ALT, and preoperative-postoperative AST values (p>0.05) ( Table 4 ).
The postoperative ALT value did not show a significant change compared to the preoperative period (p>0.05), while the postoperative AST value showed a significant change compared to the preoperative period (p<0.05). The postoperative BUN value did not show a significant change compared to the preoperative period (p>0.05). The postoperative creatinine value showed a significant increase compared to the preoperative period (p<0.05). The postoperative hematocrit value also showed a significant increase compared to the preoperative period (p<0.05) ( Table 5) .
DISCUSSION
There are still serious problems in the prevention of complications despite the developments in cardiac surgery and its follow-up care. Complications appear to depend on many pre-, intra-, and postoperative variables. Besides the risk factors depending on multiple variables, it is also a major problem that results are not specific to present complications. As a result, it seems not possible to draw a certain way in the prevention of complications.
Several complications occur during mitral valve and other cardiac surgeries. This is associated with several variables such as the etiology of the disease, the presence of concomitant systemic diseases, surgical technique, cardiopulmonary bypass time and intensive care given in the postoperative period. Common postoperative complications involve hemorrhage, ischemic heart damage, intracranial ischemic injury and cardiac tamponade as well as renal, pulmonary and gastrointestinal problems.
It is of vital importance to ensure adequate renal function during cardiac surgery. Coffin et al. (5) revealed the serious correlation between the perioperative mortality and renal failure. Antunes et al. (6) concluded that postoperative renal dysfunction led to a dramatic increase in mortality, morbidity and hospitalization time after coronary artery bypass grafting (CABG). The present study also yielded a significant positive correlation between the duration of ICU stay and postoperative renal dysfunction indicators. The postoperative creatinine value showed a significant increase compared to the preoperative period.
Mitral valve surgery represents a high-risk surgical group in terms of pulmonary complications. Significant deficiency may occur in pulmonary functions due to surgical intervention, median sternotomy, effects of anesthesia and cardiopulmonary bypass (7) . Furthermore, in the preoperative period, pulmonary functional alterations secondary to the elevated left atrial pressure in mitral valve disease also have a negative impact on postoperative pulmonary function. Preexisting diseases such as COPD are also primary factors that lead to postoperative pulmonary dysfunction and thus prolonged mechanical ventilation and hospital stay. In previous studies it was indicated that a low preoperative FEV1 and duration of anesthesia longer than 2 hours are among factors that increase complications in such patients (8,9).
Today, durations of both intubation and ICU stay have decreased thanks to advanced anesthesia techniques, postoperative intensive care and treatment methods. Accordingly, it is of great importance for early ambulation to carefully evaluate patients in terms of prolonged intubation and prolonged length of ICU stay, and to take necessary measures in the preoperative assessment. Prolonged mechanical ventilation and prolonged ICU stay not only affect morbidity but also increase economic burden and prevent the use of equipment. Thus, it seems critical to monitor more closely patients with risk factors such as COPD and to take measures in the preoperative period in order to shorten the duration of mechanical ventilation and ICU stay. Short-term pulmonary care administered to patients prior to major surgical interventions has been reported to have better outcomes in the postoperative period (10, 11) . In the present study, the duration of ICU stay was found significantly shorter in patients diagnosed with COPD than in those not diagnosed. We believe that detailed Prolonged intubation and ICU stay increase not only hospital costs but also mortality and morbidity rates (12) (13) (14) . In our study, a significant negative correlation was also found between FEV1 and duration of intubation in patients who underwent mitral valve surgery.
As in all cardiopulmonary bypass surgeries, in mitral valve surgery, there are some changes in the lungs. Due to preoperative pulmonary adverse effects in patients with mitral valve disease, pulmonary dysfunction can be much triggered by the effects of cardiopulmonary bypass. Within the first postoperative 48 hours, there may be decreased compliance based on the fluid extravasation in the lungs, and reversible pulmonary dysfunction. The effects of cardiopulmonary bypass on pulmonary functions occur with the activation of the complement system. Activated neutrophils increase the pulmonary vascular permeability and lead to the development of pulmonary edema. Atelectasis develops as a result of changes in the alveolar surfactant composition and less effective alveolar stability, and atelectasis maintains its effectiveness over the first 48 hours after CPB. Functional residual volume and pulmonary compliance are reduced. An increase appears in the physiological shunts and alveolar-arterial oxygen difference (15) . The decrease in cardiopulmonary compliance is directly proportional to the bypass time (16). Cislaghi et al. (17) indicated that prolonged cardiopulmonary bypass time (over 91 minutes) was an independent predictor of prolonged mechanical ventilation. Our study also showed that there was a significant positive correlation between the cardiopulmonary bypass time and the duration of intubation.
Prolonged durations of intubation and ICU stay after mitral valve surgery are associated with increased morbidity, mortality and hospital costs. The results of our study indicated that the duration of ICU stay was shorter in patients with COPD and those with a history of medication. As these patients were supported with prophylactic treatment and their preoperative pulmonary functions were evaluated in detail, it was resulted in better postoperative pulmonary outcomes, shortened ICU stay and decreased mortality.
In our study, a high FEV1 was identified as a valuable parameter for determining postoperative morbidity. The duration of ICU stay was shortened in COPD patients with airway obstruction as a result of the preoperative assessment and treatment. Awareness of the disease was found together with positive outcomes with respect to postoperative morbidity.
LIMITATIONS
There are some limitations of the current study. First of all this is a retrospective study and we did not have a control group. Therefore future prospective controlled trials are needed. Before the study a detailed pulmonary function analyze should be done using body plethysmography.
CONCLUSION
Considering patients who have been scheduled for mitral valve replacement, preoperative measures are regarded to be important factors in determining postoperative morbidity especially in patients with a low FEV1 value in the preoperative spirometric evaluation and those diagnosed with COPD. The impact of postoperative complications on morbidity and mortality can be minimized through preoperative assessment that helps to predict postoperative complications.
Preoperative pulmonary regime should be followed in COPD patients for the purpose of optimal lung function and minimal airway secretion. This regime entails smoking cessation, intense inhaled bronchodilator administration, and the use of oral antibiotic in patients with purulent secretions and cough. In preoperative period, patients should be taught how to work with a breathing exercise machine as well as coughing and breathing techniques. Patients with a significant bronchospastic component should be given a shortterm treatment with oral corticosteroids. We concluded that such simple and cost effective methods can significantly reduce the incidence of postoperative pulmonary complications.
